Blonder Tongue Laboratories, Inc.
BDRL
$0.21
$0.000.00%
Weiss Ratings | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Fair | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.08 | |||
Price History | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 6.60% | |||
30-Day Total Return | -29.53% | |||
60-Day Total Return | 31.25% | |||
90-Day Total Return | 16.47% | |||
Year to Date Total Return | 23.53% | |||
1-Year Total Return | -70.09% | |||
2-Year Total Return | -85.62% | |||
3-Year Total Return | -65.59% | |||
5-Year Total Return | -73.42% | |||
52-Week High % Change | -72.73% | |||
52-Week Low % Change | 110.00% | |||
Price | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.77 | |||
52-Week Low Price | $0.10 | |||
52-Week Low Price (Date) | Jun 27, 2022 | |||
52-Week High Price (Date) | Apr 21, 2022 | |||
Valuation | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | $3.21M | |||
Enterprise Value | 13.86M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.32 | |||
Earnings Per Share Growth | 74.25% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.19 | |||
Price/Book (Q) | 3.40 | |||
Enterprise Value/Revenue (TTM) | 0.80 | |||
Price | $0.21 | |||
Enterprise Value/EBITDA (TTM) | -4.41 | |||
Enterprise Value/EBIT | -4.16 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 13.333M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 732 679 4000 | |||
Address | One Jake Brown Road Old Bridge, NJ 08857 | |||
Website | www.blondertongue.com | |||
Country | United States | |||
Year Founded | 1950 | |||
Profitability | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -19.22% | |||
Profit Margin | -23.39% | |||
Management Effectiveness | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -14.75% | |||
Return on Equity | -- | |||
Income Statement | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | $16.83M | |||
Total Revenue (TTM) | $16.83M | |||
Revenue Per Share | $1.26 | |||
Gross Profit (TTM) | $4.78M | |||
EBITDA (TTM) | -$3.05M | |||
EBIT (TTM) | -$3.24M | |||
Net Income (TTM) | -$3.94M | |||
Net Income Avl. to Common (TTM) | -$3.94M | |||
Total Revenue Growth (Q YOY) | 26.13% | |||
Earnings Growth (Q YOY) | -249.75% | |||
EPS Diluted (TTM) | -$0.32 | |||
EPS Diluted Growth (Q YOY) | -163.50% | |||
Balance Sheet | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | $167.00K | |||
Cash Per Share (Q) | $0.01 | |||
Total Current Assets (Q) | $8.23M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | $937.00K | |||
Current Ratio (Q) | 0.973 | |||
Book Value Per Share (Q) | $0.07 | |||
Total Assets (Q) | $15.28M | |||
Total Current Liabilities (Q) | $8.46M | |||
Total Debt (Q) | $10.82M | |||
Total Liabilities (Q) | $14.34M | |||
Total Common Equity (Q) | $937.00K | |||
Cash Flow | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -$61.00K | |||
Cash from Financing (TTM) | $2.09M | |||
Net Change in Cash (TTM) | -$104.00K | |||
Levered Free Cash Flow (TTM) | -$1.05M | |||
Cash from Operations (TTM) | -$2.13M | |||